Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin J Edelman

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapyRoger Hakimian, Hongbin Fang, Leno Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Maintenance therapy and advanced non-small-cell lung cancer: a skeptic's viewMartin J Edelman, Thierry Le Chevalier, Jean-Charles Soria
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancerAmy J Davidoff, Mei Tang, Brian Seal, et al.
Neurology|March 23, 2005
West Nile virus presenting as opsoclonus-myoclonus cerebellar ataxiaJaswinder S Khosla, Martin J Edelman, Nancy Kennedy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2011
Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancerAmy J Davidoff, James F Gardner, Brian Seal, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims dataJosephine Feliciano, Lisa Gardner, Franklin Hendrick, et al.
Clinical Lung Cancer|September 27, 2025
An Institution-Specific Hypofractionated Radiation Therapy Regimen in the Treatment of Central and Ultracentral Non-small Cell Lung CancerM Judy Lubas, Albi Vata, Jordan Fredette, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Clinical Trials in the Age of PandemicsMartin J Edelman, Crystal S Denlinger, Eric A Ross, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Whole-Brain Radiation in the Treatment of Brain Metastases in ALK-Positive Non-Small-Cell Lung CancerJason K Molitoris, Martin J Edelman, William F Regine, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapyRoger Hakimian, Hongbin Fang, Leno Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 17, 2012
Maintenance therapy and advanced non-small-cell lung cancer: a skeptic's viewMartin J Edelman, Thierry Le Chevalier, Jean-Charles Soria
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2010
Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancerAmy J Davidoff, Mei Tang, Brian Seal, et al.
Neurology|March 23, 2005
West Nile virus presenting as opsoclonus-myoclonus cerebellar ataxiaJaswinder S Khosla, Martin J Edelman, Nancy Kennedy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2011
Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancerAmy J Davidoff, James F Gardner, Brian Seal, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2014
Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims dataJosephine Feliciano, Lisa Gardner, Franklin Hendrick, et al.
Clinical Lung Cancer|September 27, 2025
An Institution-Specific Hypofractionated Radiation Therapy Regimen in the Treatment of Central and Ultracentral Non-small Cell Lung CancerM Judy Lubas, Albi Vata, Jordan Fredette, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Clinical Trials in the Age of PandemicsMartin J Edelman, Crystal S Denlinger, Eric A Ross, et al.
Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2016
Whole-Brain Radiation in the Treatment of Brain Metastases in ALK-Positive Non-Small-Cell Lung CancerJason K Molitoris, Martin J Edelman, William F Regine, et al.
Pageof 19